GE Healthcare (GM) Receives FDA Approval for Change in Contraindications in Prescribing Information for Optison
Go back to GE Healthcare (GM) Receives FDA Approval for Change in Contraindications in Prescribing Information for OptisonGeneral Electric (NYSE: GE) | Delayed: 161.26 +2.07 (1.30%) | |||||
---|---|---|---|---|---|---|
Previous Close | $159.19 | 52 Week High | $33.00 | |||
Open | $158.09 | 52 Week Low | $27.10 | |||
Day High | $161.48 | P/E | 109.70 | |||
Day Low | $157.12 | EPS | $1.47 | |||
Volume | 5,906,246 |